# Bowman Consulting Group Ltd.: overview BWMN · Nasdaq · CIK 1847590 · [Industrials](/sectors/industrials.md) Pages: [Overview](/companies/bwmn.md) · [Financials](/companies/bwmn/financials.md) · [Filings](/companies/bwmn/filings.md) · [Insiders](/companies/bwmn/insiders.md) Latest reported revenue: [$146.1m](/filings/0001628280-26-055250.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-055250). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [114](/filings/0001628280-25-050314.md) | [113 d](/filings/0001628280-26-015252.md) | [113](/filings/0001628280-26-031344.md) | [122](/filings/0001628280-26-055250.md) | [126](/filings/0001628280-25-050314.md) | [129 d](/filings/0001628280-26-015252.md) | [126](/filings/0001628280-26-031344.md) | [146](/filings/0001628280-26-055250.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [0.4%](/filings/0001628280-25-050314.md) | [1.2% d](/filings/0001628280-26-015252.md) | [1.0%](/filings/0001628280-26-031344.md) | [7.4%](/filings/0001628280-26-055250.md) | [4.2%](/filings/0001628280-25-050314.md) | [3.2% d](/filings/0001628280-26-015252.md) | [0.1%](/filings/0001628280-26-031344.md) | [5.6%](/filings/0001628280-26-055250.md) | | Net margin | % | [0.7%](/filings/0001628280-25-050314.md) | [5.2% d](/filings/0001628280-26-015252.md) | [(1.5%)](/filings/0001628280-26-031344.md) | [4.9%](/filings/0001628280-26-055250.md) | [5.3%](/filings/0001628280-25-050314.md) | [1.5% d](/filings/0001628280-26-015252.md) | [(2.9%)](/filings/0001628280-26-031344.md) | [1.7%](/filings/0001628280-26-055250.md) | | Diluted EPS | $ per share | [0.04](/filings/0001628280-25-050314.md) | not reported | [(0.11)](/filings/0001628280-26-031344.md) | [0.34](/filings/0001628280-26-055250.md) | [0.37](/filings/0001628280-25-050314.md) | not reported | [(0.22)](/filings/0001628280-26-031344.md) | [0.14](/filings/0001628280-26-055250.md) | | Free cash flow | $m | [6.6 d](/filings/0001628280-25-050314.md) | [11.7 d](/filings/0001628280-26-015252.md) | [11.0](/filings/0001628280-26-031344.md) | [4.2 d](/filings/0001628280-26-055250.md) | [10.1 d](/filings/0001628280-25-050314.md) | [8.1 d](/filings/0001628280-26-015252.md) | [9.6](/filings/0001628280-26-031344.md) | [(15.3) d](/filings/0001628280-26-055250.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [150](/filings/0001628280-23-008120.md) | [262](/filings/0001628280-24-010652.md) | [346](/filings/0001628280-25-012365.md) | [427](/filings/0001628280-26-015252.md) | [490](/filings/0001628280-26-015252.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [0.1%](/filings/0001628280-23-008120.md) | [2.0%](/filings/0001628280-24-010652.md) | [(0.2%)](/filings/0001628280-25-012365.md) | [(0.5%)](/filings/0001628280-26-015252.md) | [4.0%](/filings/0001628280-26-015252.md) | | Net margin | % | [0.2%](/filings/0001628280-23-008120.md) | [1.9%](/filings/0001628280-24-010652.md) | [(1.9%)](/filings/0001628280-25-012365.md) | [0.7%](/filings/0001628280-26-015252.md) | [2.6%](/filings/0001628280-26-015252.md) | | Diluted EPS | $ per share | [0.03](/filings/0001628280-23-008120.md) | [0.37](/filings/0001628280-24-010652.md) | [(0.53)](/filings/0001628280-25-012365.md) | [0.17](/filings/0001628280-26-015252.md) | [0.73](/filings/0001628280-26-015252.md) | | Free cash flow | $m | [3.8](/filings/0001628280-23-008120.md) | [8.3](/filings/0001628280-24-010652.md) | [9.6](/filings/0001628280-25-012365.md) | [23.7](/filings/0001628280-26-015252.md) | [33.4](/filings/0001628280-26-015252.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bwmn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $70.1m | 2,399,322 | | Reduced −101,568 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $31.1m | 1,065,510 | | Added +76,167 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $18.5m | 634,836 | | Added +24,805 | | [Swedbank AB](/funds/946431.md) | 2026-06-30 | $12.6m | 430,000 | | Reduced −20,000 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $11.9m | 409,019 | | Added +31,220 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.9m | 373,972 | | Added +23,778 | | [Mill Road Capital Management LLC](/funds/1512275.md) | 2026-06-30 | $9.7m | 333,872 | | Added +123,539 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.5m | 290,547 | | Added +9,738 | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $8.1m | 276,963 | | Added +31,411 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $7.7m | 264,794 | | Added +77,890 | ## Recent filings [All 511 filings](/companies/bwmn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 16:50 ET | [8-K](/filings/0001140361-26-040909.md) | 8.01 Other events | 0001140361-26-040909 | | 2026-10-22 | 16:07 ET | [SCHEDULE 13D/A](/filings/0000929638-26-003987.md) | Ownership report, active investor, amended | 0000929638-26-003987 | | 2026-09-14 | 08:37 ET | [8-K](/filings/0001193125-26-389902.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389902 | | 2026-08-10 | 16:18 ET | [10-Q](/filings/0001628280-26-055250.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055250 | | 2026-08-10 | 09:21 ET | [8-K](/filings/0001193125-26-341431.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-341431 | | 2026-06-03 | 16:30 ET | [8-K](/filings/0001193125-26-255564.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-255564 | | 2026-05-06 | 16:27 ET | [10-Q](/filings/0001628280-26-031344.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031344 | | 2026-05-05 | 17:26 ET | [8-K](/filings/0001628280-26-030749.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030749 | | 2026-04-28 | 16:01 ET | [DEF 14A](/filings/0001193125-26-186892.md) | Proxy statement, period 2026-05-28 | 0001193125-26-186892 | | 2026-04-17 | 17:02 ET | [8-K](/filings/0001193125-26-161761.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-161761 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-015252.md), filed Mar 5, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bf2a1e9c-b074-4571-b5af-d4d14d449280) ## About the filer - CIK: 1847590 - Tickers: BWMN - Exchange: Nasdaq - SIC code: 8742 Services-Management Consulting Services - State of incorporation: not reported - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:53 ET. No prices; not investment advice.